Jewel Johl works in the field of Oncology. He went to Loyola University Chicago Stritch School of Medicine. He over the years received 1 awards: "CMS Meaningful Use Stage 1 Certification". Jewel Johl is also a published MD. He has 2 paper published. The most recent paper is: A population-based clinical trial of irinotecan and Carboplatin. He accepts Medicare.
NPI NUMBER | 1407852858 | |
NPPES Provider LastName | JOHL | |
NPPES Provider FirstName | JEWEL | |
NPPES Provider ZIPCode | 945232147 | |
NPPES Provider State | CA | |
Specialty Description | Hematology/Oncology | |
Total Claim Count | 623.0 | |
Distinct Opioid Count | 3.0 | |
Opioid Claim Count | 44.0 | |
Percent Opioid Claims | 7.06 |
National Provider Identifier [NPI] | 1407852858 |
Last Name Of The Provider | JOHL |
First Name Of The Provider | JEWEL |
View All |
![]() |
Dr. Kasra Karamlou, MD
![]() ![]() |